The Corporate Practice of Medicine: Strengthening Prohibitions for a Just Healthcare System

The Corporate Practice of Medicine: Strengthening Prohibitions for a Just Healthcare System

Introduction:
In the evolving landscape of healthcare, the corporate practice of medicine has become a growing concern. Driven by increased market power and aggressive revenue models, corporate entities are encroaching on the clinical operations, decision-making processes, and even the delivery of care. Despite the existence of laws such as the corporate-practice-of-medicine (CPOM) doctrine, the expansion of corporate influence in healthcare continues. This article delves into the reasons behind this phenomenon and explores strategies to strengthen prohibitions against the corporate practice of medicine, ultimately protecting the medical profession and the public interest.

The Rise of Corporate Influence:
The transition from independent physician practices to corporate ownership has been significant. Currently, nearly three quarters of physicians in the United States are salaried employees, with half of all practices owned by hospitals or corporate entities. This shift has prompted concerns about the erosion of physician autonomy and the potential impact on patient care. The CPOM doctrine was introduced as a means to prevent unlicensed lay entities from owning or controlling medical practices, but its effectiveness in curbing corporate influence has been limited.

The Risks of Corporatized Medicine:
Emerging evidence highlights three primary risks associated with corporatized medicine. Firstly, market consolidation and exploitation of payment loopholes have led to increased healthcare prices and spending. This has profound implications for healthcare accessibility and affordability, exacerbating existing disparities. Secondly, changes in practice patterns and pressures to reduce staffing have raised concerns about the quality of patient care. Lastly, physicians are experiencing moral injury and burnout due to the corporate influence on their practice, which compromises their ability to deliver patient-centered care.

Circumventing CPOM Laws:
One reason why CPOM laws have not effectively prevented corporatization is the use of management-services agreements (MSAs). These agreements allow corporate entities to circumvent restrictions by providing services to physician-owned entities. By exerting control over clinical operations, staffing decisions, and financial aspects, these entities blur the line between administrative support and clinical control. Additionally, stock-restriction agreements, noncompete clauses, and nondisclosure agreements further solidify corporate control.

Strengthening Prohibitions:
To protect the integrity of the medical profession and ensure patient-centered care, it is crucial to strengthen prohibitions against the corporate practice of medicine. Three actionable strategies can be considered:

1. Close Existing Loopholes:
   States should review and revise their laws to close existing loopholes that permit corporate ownership. For example, requirements for physician ownership should extend to all types of entities delivering medical services, including limited-liability companies and partnerships. By eliminating these loopholes, the ultimate control of medical practices can be ensured by licensed professionals.

2. Enhance Enforcement Mechanisms:
   To enforce CPOM laws effectively, regulatory bodies should be empowered with adequate resources and authority. Strengthening oversight and monitoring systems can help identify instances of corporate control and ensure compliance with the spirit of the law. Clear penalties and consequences for violations should also be established to deter corporate entities from engaging in the practice of medicine.

3. Promote Physician-led Models:
   Encouraging and supporting physician-led models of care can help preserve the autonomy and professionalism of the medical field. By providing incentives and resources for independent practices, physicians can maintain control over clinical decisions and prioritize patient needs over corporate interests. Collaborative efforts between medical associations, academic institutions, and policymakers can assist in developing and promoting these models.

Conclusion:
The corporate practice of medicine poses significant challenges to the healthcare system, affecting both physicians and patients. By understanding the reasons behind the continued expansion of corporate influence and implementing strategies to strengthen prohibitions, we can work towards a more just and equitable healthcare system. Closing loopholes, enhancing enforcement mechanisms, and promoting physician-led models are actionable steps that can protect the medical profession and prioritize patient care over corporate interests. Through collaborative efforts, we can shape a future where healthcare is driven by the needs of patients and guided by the expertise of physicians.